Nomenclatura brasileira para laudos cervicais e condutas
Nomenclatura brasileira para laudos cervicais e condutas
Nomenclatura brasileira para laudos cervicais e condutas
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REFERÊNCIAS<br />
1. Instituto Nacional de Câncer; Ministério da Saúde. Estimativa 2006: incidência de<br />
câncer no Brasil. Rio de Janeiro (Brasil): INCA; 2005.<br />
2. Instituto Nacional de Câncer; Ministério da Saúde. Inquérito domiciliar sobre comportamentos<br />
de risco e morbidade referida de doenças e agravos não transmissíveis: Brasil,<br />
15 capitais e Distrito Federal, 2002-2003. Rio de Janeiro (Brasil): INCA; 2004.<br />
3. Instituto Brasileiro de Geografia e Estatística. PNAD 2005: Pesquisa Nacional por<br />
Amostra de Domicílios. IBGE.<br />
4. Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M. The 2001 Bethesda<br />
System: terminology for reporting results of cervical cytology. JAMA. 2002 Apr<br />
24;287(16):2114-9.<br />
5. Koss GL, Melamed RM. Koss’ diagnostic cytology and its histopathologic bases.<br />
5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.<br />
6. Instituto Nacional de Câncer; Ministério da Saúde. Periodicidade de realização do<br />
exame preventivo do câncer do colo do útero: normas e recomendações do INCA. Rev<br />
Bras Cancerol. 2002;48(1):13-5.<br />
7. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ; ASCCP-Sponsored<br />
Consensus Conference. 2001 Consensus Guidelines for the management of women<br />
with cervical cytological abnormalities. JAMA. 2002 Apr 24;287(16):2120-9.<br />
8. Solomon D, Frable WJ, Vooijs GP, Wilbur DC, Amma NS, Collins RJ, et al. ASCUS<br />
and AGUS criteria. International Academy of Cytology Task Force summary. Diagnostic<br />
Cytology Towards the 21st Century: An International Expert Conference and Tutorial.<br />
Acta Cytol.1998;42(1):16-24.<br />
9. Solomon D, Schiffman M, Tarone R; ALTS Study Group. Comparison of three management<br />
strategies for patients with atypical squamous cells of undetermined significance:<br />
baseline results from a randomized trial. J Natl Cancer Inst. 2001 Feb 21;93(4):293-9.<br />
10. Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, et al.<br />
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat<br />
Pap smear, HPV DNA testing, or colposcopy? J Fam Pract. 1998;46(2):125-34.<br />
11. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ,<br />
et al. Identifying women with cervical neoplasia: using human papillomavirus DNA<br />
testing for equivocal Papanicolaou results. Identifying women with cervical neoplasia.<br />
JAMA. 1999;28(17):1605-10. Comment in: JAMA. 1999 May 5;281(17):1645-7.<br />
12. Bergeron C, Jeannel D, Poveda J, Cassonnet P, Orth G. Human papillomavirus testing<br />
in women with mild cytologic atypia. Obstet Gynecol. 2000 Jun;95(6 Pt 1):821-7.<br />
45